SCHEMBL23485994

SCHEMBL23485994

CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(O)Nc1ccc(O)c(C(=O)O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 4/20 0.43
▸ PPARA Q07869 1/20 0.41
▸ STING1 Q86WV6 1/20 0.41
▸ ALDH1A1 P00352 4/20 0.40
▸ ALOX12 P18054 1/20 0.39
▸ MAPT P10636 5/20 0.39
▸ NOX4 Q9NPH5 2/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ RGS12 O14924 1/20 0.39
▸ EGFR P00533 1/20 0.39
▸ LCK P06239 1/20 0.39
▸ CAMKK2 Q96RR4 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ AKR1C3 P42330 2/20 0.37
▸ POLB P06746 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23485995 0.86 KMT2A (0.48) ALDH1A1ALOX12MAPTTDP1EGFR
SCHEMBL14694703 0.81 LMNA (0.46) KDM4CALDH1A1MAPTTDP1MEN1
SCHEMBL14694702 0.81 LMNA (0.46) KDM4CALDH1A1MAPTTDP1MEN1
SCHEMBL455989 0.78 KDM4C (0.55) KDM4CALDH1A1ALOX12MAPTTDP1
SCHEMBL469470 0.78 KDM4C (0.55) KDM4CALDH1A1ALOX12MAPTTDP1
SCHEMBL2677643 0.76 CNR1 (0.59) KDM4CPPARAALDH1A1MAPTEGFR
SCHEMBL2677644 0.76 CNR1 (0.59) KDM4CPPARAALDH1A1MAPTEGFR
SCHEMBL12519153 0.75 KDM4C (0.43) KDM4CALOX12MAPTTDP1MEN1
SCHEMBL14695067 0.75 KDM4C (0.43) KDM4CALOX12MAPTTDP1MEN1
SCHEMBL1822036 0.74 CNR1 (0.57) KDM4CPPARAALDH1A1MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210169905-A1 FATTY ACID ACETYLATED SALICYLATES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. 2021-06-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210169905-A1 FATTY ACID ACETYLATED SALICYLATES AND THEIR USES FASN, ACACA, FABP4 KDM4C 2592/4885PPARA 21/4885STING1 1246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback